Treatment of recurrent or persistent platinum-refractory ovarian, fallopian tube or primary peritoneal cancer with gemcitabine and topotecan: a phase II trial of the Puget Sound Oncology Consortium. (Q46552205)
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment of recurrent or persistent platinum-refractory ovarian, fallopian tube or primary peritoneal cancer with gemcitabine and topotecan: a phase II trial of the Puget Sound Oncology Consortium. |
scientific article |
Statements
1 reference
Treatment of recurrent or persistent platinum-refractory ovarian, fallopian tube or primary peritoneal cancer with gemcitabine and topotecan: a phase II trial of the Puget Sound Oncology Consortium. (English)
1 reference
Barbara A Goff
1 reference
Leona A Holmberg
1 reference
Dan Veljovich
1 reference
Brenda F Kurland
1 reference
Puget Sound Oncology Consortium
1 reference
6 June 2008
1 reference
1 reference
110
1 reference
2
1 reference
146-151
1 reference